Company news

LENZ Therapeutics, Inc. news in 2025

LENZ Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia

November 30, 2025

LENZ Therapeutics to Present at Upcoming Investor Conferences

November 24, 2025

LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

November 4, 2025

LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025

October 28, 2025

LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States

September 29, 2025

LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States

September 29, 2025

LENZ Therapeutics to Present at Upcoming Investor and Medical Conferences

August 24, 2025

LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia

July 30, 2025

LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

July 29, 2025

LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia

July 27, 2025

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada

July 6, 2025

LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia

May 8, 2025

LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 6, 2025

LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference

May 5, 2025

LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025

April 29, 2025

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

March 18, 2025

LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025

March 10, 2025

LENZ Therapeutics to Host Commercial Day on April 15, 2025

March 2, 2025

LENZ Therapeutics to Participate in Upcoming Investor Conferences

February 23, 2025

Calls in 2025

Decks in 2025